These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23782096)
1. Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry. Ko CH; Cheng CF; Lai CP; Tzu TH; Chiu CW; Lin MW; Wu SY; Sun CY; Tseng HW; Wang CC; Kuo ZK; Wang LM; Chen SF J Proteome Res; 2013 Aug; 12(8):3573-85. PubMed ID: 23782096 [TBL] [Abstract][Full Text] [Related]
2. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084 [TBL] [Abstract][Full Text] [Related]
3. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424 [TBL] [Abstract][Full Text] [Related]
4. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course. Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025 [TBL] [Abstract][Full Text] [Related]
5. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977 [TBL] [Abstract][Full Text] [Related]
6. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells. Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355 [TBL] [Abstract][Full Text] [Related]
7. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity. Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286 [TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective. Chiba T; Kamiya A; Yokosuka O; Iwama A Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789 [TBL] [Abstract][Full Text] [Related]
9. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425 [TBL] [Abstract][Full Text] [Related]
10. β-catenin plays a key role in metastasis of human hepatocellular carcinoma. Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1. Yang L; Ji J; Chen Z; Wang H; Li J Neoplasma; 2014; 61(2):193-204. PubMed ID: 24299315 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186 [TBL] [Abstract][Full Text] [Related]
13. Significance of CD90+ cancer stem cells in human liver cancer. Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515 [TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
15. Biology of hepatic cancer stem cells. Tong CM; Ma S; Guan XY J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770 [TBL] [Abstract][Full Text] [Related]
16. Primary liver tumors: origin and target therapy. Papoulas M; Theocharis S Expert Opin Ther Targets; 2009 Aug; 13(8):957-65. PubMed ID: 19606929 [TBL] [Abstract][Full Text] [Related]
17. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach. Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546 [TBL] [Abstract][Full Text] [Related]
18. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Xu XL; Xing BC; Han HB; Zhao W; Hu MH; Xu ZL; Li JY; Xie Y; Gu J; Wang Y; Zhang ZQ Carcinogenesis; 2010 Feb; 31(2):167-74. PubMed ID: 19897602 [TBL] [Abstract][Full Text] [Related]
19. Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis. Liu Y; Li C; Xing Z; Yuan X; Wu Y; Xu M; Tu K; Li Q; Wu C; Zhao M; Zeng R FEBS J; 2010 Oct; 277(19):4039-53. PubMed ID: 20807235 [TBL] [Abstract][Full Text] [Related]
20. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]